Sixty patients with spinal cord stimulators implanted for intractable pain lasting up to 50 years were followed for up to nine years. Forty seven per cent derived significant benefit, 23% modest benefit, 20% experienced no effect and 6-7% were made worse. Two were made worse after initial benefit. Complications, indications and factors relevant to the mode of action are discussed.
Materials and methods
Results Four patients (6-7%) were made worse. All were male but there were no other common features. Another two were made worse after initial benefit; one had developed an aversion to the implanted device after several months of MB and the other change occurred after three years and six months of SB in a man with facial anaesthesia dolorosa who developed primary hyperparathyroidism. Twelve patients (20%) reported no effect on their pain; there were no common features. Modest benefit was gained by 14 (23.3%) and significant benefit by 28 (46-7%). Thus 70% derived benefit. Overall, 10 patients experienced complete relief of their pain, three had virtually complete relief and three who had The three patients with complete paraplegia 
